PT Erlangga Edi Laboratories (Indonesia)

Erlangga Edi Laboratories is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Jawa Tengah. The company was founded in 1965. Erlangga Edi Laboratories was established by Dr. Erlangga Edi, a visionary in the pharmaceutical industry, with a mission to improve healthcare through innovative and affordable medication. The company focuses on the development and manufacturing of a wide range of pharmaceutical products, including prescription drugs, over-the-counter medications, and health supplements. With a strong presence in Indonesia, Erlangga Edi Laboratories operates several branches across the country, ensuring widespread distribution and accessibility of its products. The company is known for its flagship brands, which include popular medications for cardiovascular health, diabetes management, and pain relief. In addition to its domestic operations, Erlangga Edi Laboratories has expanded its reach to several Southeast Asian countries, establishing a growing footprint in the region. The company is committed to maintaining high standards of quality and compliance, adhering to international pharmaceutical regulations. Erlangga Edi Laboratories collaborates with various healthcare organizations and research institutions to advance pharmaceutical research and development. It is a member of several industry associations, actively participating in initiatives to enhance the pharmaceutical sector. The company is dedicated to sustainable practices and community health initiatives, aiming to contribute positively to society. Erlangga Edi Laboratories envisions a future where healthcare is accessible to all, driven by its core values of innovation, integrity, and excellence.